Discovery of potent and selective agonists for the free fatty acid receptor 1 (FFA(1)/GPR40), a potential target for the treatment of type II diabetes
- PMID: 18947221
- DOI: 10.1021/jm8010178
Discovery of potent and selective agonists for the free fatty acid receptor 1 (FFA(1)/GPR40), a potential target for the treatment of type II diabetes
Abstract
A series of 4-phenethynyldihydrocinnamic acid agonists of the free fatty acid receptor 1 (FFA(1)) has been discovered and explored. The preferred compound 20 (TUG-424, EC(50) = 32 nM) significantly increased glucose-stimulated insulin secretion at 100 nM and may serve to explore the role of FFA(1) in metabolic diseases such as diabetes or obesity.
Similar articles
-
Discovery of a potent and selective GPR120 agonist.J Med Chem. 2012 May 10;55(9):4511-5. doi: 10.1021/jm300215x. Epub 2012 May 2. J Med Chem. 2012. PMID: 22519963
-
Optimization of (2,3-dihydro-1-benzofuran-3-yl)acetic acids: discovery of a non-free fatty acid-like, highly bioavailable G protein-coupled receptor 40/free fatty acid receptor 1 agonist as a glucose-dependent insulinotropic agent.J Med Chem. 2012 Apr 26;55(8):3960-74. doi: 10.1021/jm300170m. Epub 2012 Apr 18. J Med Chem. 2012. PMID: 22490067
-
The Discovery, Preclinical, and Early Clinical Development of Potent and Selective GPR40 Agonists for the Treatment of Type 2 Diabetes Mellitus (LY2881835, LY2922083, and LY2922470).J Med Chem. 2016 Dec 22;59(24):10891-10916. doi: 10.1021/acs.jmedchem.6b00892. Epub 2016 Nov 11. J Med Chem. 2016. PMID: 27749056
-
GPR40: a therapeutic target for mediating insulin secretion (review).Int J Mol Med. 2012 Dec;30(6):1261-6. doi: 10.3892/ijmm.2012.1142. Epub 2012 Sep 26. Int J Mol Med. 2012. PMID: 23023155 Review.
-
Structural basis for the agonist action at free fatty acid receptor 1 (FFA1R or GPR40).Chem Biol Drug Des. 2018 Mar;91(3):668-680. doi: 10.1111/cbdd.13131. Epub 2017 Nov 16. Chem Biol Drug Des. 2018. PMID: 29068547 Review.
Cited by
-
Pharmacophore-guided repurposing of fibrates and retinoids as GPR40 allosteric ligands with activity on insulin release.J Enzyme Inhib Med Chem. 2021 Dec;36(1):377-383. doi: 10.1080/14756366.2020.1864629. J Enzyme Inhib Med Chem. 2021. PMID: 33525941 Free PMC article.
-
Deconvolution of complex G protein-coupled receptor signaling in live cells using dynamic mass redistribution measurements.Nat Biotechnol. 2010 Sep;28(9):943-9. doi: 10.1038/nbt.1671. Epub 2010 Aug 15. Nat Biotechnol. 2010. PMID: 20711173
-
Oral administration of linoleic acid immediately before glucose load ameliorates postprandial hyperglycemia.Front Pharmacol. 2023 Jul 31;14:1197743. doi: 10.3389/fphar.2023.1197743. eCollection 2023. Front Pharmacol. 2023. PMID: 37583904 Free PMC article.
-
Treatment of type 2 diabetes by free Fatty Acid receptor agonists.Front Endocrinol (Lausanne). 2014 Aug 28;5:137. doi: 10.3389/fendo.2014.00137. eCollection 2014. Front Endocrinol (Lausanne). 2014. PMID: 25221541 Free PMC article. Review.
-
Discovery of TUG-770: A Highly Potent Free Fatty Acid Receptor 1 (FFA1/GPR40) Agonist for Treatment of Type 2 Diabetes.ACS Med Chem Lett. 2013 May 9;4(5):441-445. doi: 10.1021/ml4000673. Epub 2013 Apr 8. ACS Med Chem Lett. 2013. PMID: 23687558 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Chemical Information
Medical
Molecular Biology Databases